Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

3.5K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

6.3K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.3K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

28.6K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.6K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

4.1K
4.1K
Embryonic Stem Cells00:57

Embryonic Stem Cells

6.0K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
6.0K
Embryonic Stem Cells00:58

Embryonic Stem Cells

33.5K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
33.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elucidating Mechanisms of Hypomorphic WDR19-Related Kidney Failure.

Kidney international reports·2025
Same author

Human fetal kidney organoids model early human nephrogenesis and Notch-driven cell fate.

The EMBO journal·2025
Same author

Nephron-Specific <i>Lin28A</i> Overexpression Triggers Severe Inflammatory Response and Kidney Damage.

International journal of biological sciences·2024
Same author

Characterization of Alternative Splicing in High-Risk Wilms' Tumors.

International journal of molecular sciences·2024
Same author

Characterization of Continuous Transcriptional Heterogeneity in High-Risk Blastemal-Type Wilms' Tumors Using Unsupervised Machine Learning.

International journal of molecular sciences·2023
Same author

Characterization of alternative mRNA splicing in cultured cell populations representing progressive stages of human fetal kidney development.

Scientific reports·2022

Related Experiment Video

Updated: Apr 6, 2026

Author Spotlight: Advancements in iPSCs and Genetic Disease Research
06:24

Author Spotlight: Advancements in iPSCs and Genetic Disease Research

Published on: October 20, 2023

2.0K

Comparing ESC and iPSC-Based Models for Human Genetic Disorders.

Tomer Halevy1, Achia Urbach2

  • 1Stem Cell Unit, Department of Genetics, Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 91904, Israel. tomerhalevy@gmail.com.

Journal of Clinical Medicine
|August 4, 2015
PubMed
Summary

Human stem cell models offer new ways to study genetic diseases. This review compares human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) for disease modeling, guiding optimal strategy selection.

Keywords:
disease modelingembryonic stem cells (ESCs)induced pluripotent stem cells (iPSCs)

More Related Videos

2D and 3D Human Induced Pluripotent Stem Cell-Based Models to Dissect Primary Cilium Involvement during Neocortical Development
14:19

2D and 3D Human Induced Pluripotent Stem Cell-Based Models to Dissect Primary Cilium Involvement during Neocortical Development

Published on: March 25, 2022

4.5K
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

9.4K

Related Experiment Videos

Last Updated: Apr 6, 2026

Author Spotlight: Advancements in iPSCs and Genetic Disease Research
06:24

Author Spotlight: Advancements in iPSCs and Genetic Disease Research

Published on: October 20, 2023

2.0K
2D and 3D Human Induced Pluripotent Stem Cell-Based Models to Dissect Primary Cilium Involvement during Neocortical Development
14:19

2D and 3D Human Induced Pluripotent Stem Cell-Based Models to Dissect Primary Cilium Involvement during Neocortical Development

Published on: March 25, 2022

4.5K
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

9.4K

Area of Science:

  • Biomedical Research
  • Stem Cell Biology
  • Disease Modeling

Background:

  • Traditional methods like animal models and somatic cells have limitations in modeling complex genetic human disorders.
  • Human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) have revolutionized disease modeling.
  • Genome editing technologies further enhance the capabilities of stem cell-based disease research.

Purpose of the Study:

  • To compare human embryonic stem cell (ESC)-based disease models with induced pluripotent stem cell (iPSC)-based models.
  • To highlight the advantages and disadvantages of both ESC and iPSC systems for disease modeling.
  • To provide a strategic roadmap for selecting the optimal stem cell model for specific disorders.

Main Methods:

  • Comparative analysis of ESCs and iPSCs for disease modeling applications.
  • Review of existing literature on stem cell-based disease models.
  • Discussion of fundamental differences between ESCs and iPSCs relevant to disease modeling.

Main Results:

  • Both ESCs and iPSCs offer significant advantages over traditional models for studying human genetic diseases.
  • Key differences exist between ESCs and iPSCs that impact their suitability for specific disease modeling contexts.
  • Genome editing in pluripotent stem cells provides powerful tools for dissecting disease mechanisms.

Conclusions:

  • ESC- and iPSC-based models represent powerful tools for understanding human genetic disorders.
  • Careful consideration of the unique properties of ESCs and iPSCs is crucial for successful disease modeling.
  • A strategic approach is needed to select the most appropriate stem cell model for each specific disorder.